RAK-based Julphar taps IBM, SAP for major digital overhaul
IBM Consulting leads massive migration to SAP S/4HANA cloud
#UAE #digitaltransformation - Regional drug manufacturer Gulf Pharmaceutical Industries (also known as Julphar) has launched a sweeping modernization initiative in partnership with IBM and SAP. The commercial turnaround plan involves migrating all core corporate functions to the advanced SAP S/4HANA cloud ecosystem. The initiative aims to upgrade outdated legacy software, secure strict compliance across forty export markets, and establish an automated digital core. Global systems integrator IBM Consulting will oversee the comprehensive engineering rollout across the firm’s ten international factories. The software transition targets critical upgrades inside finance, supply chain logistics, manufacturing lines, and human resource systems.
SO WHAT? - The new deal seems to highlight Julphar’s intent to move rapidly away from rigid, legacy infrastructure to embrace intelligent cloud systems. By overhauling its entire technical foundation, the company aims to create a next-level intelligent enterprise, with highly automated, data-driven production. In addition, the life sciences sector requires absolute compliance, making real-time transparency across global supply chains essential. So, by moving toward cloud automation, Julphar is also positioning itself well to defend its market against potential competitors.
KEY POINTS:
Julphar (Gulf Pharmaceutical Industries) has formed a strategic technical partnership with global systems integrator IBM Consulting and enterprise software giant SAP to completely overhaul its infrastructure.
The major software modernization program will transition the pharmaceutical firm from its legacy enterprise systems over to the cloud-native RISE with SAP S/4HANA platform.
IBM Consulting will manage the end-to-end delivery of the transformation, deploying its AI-driven delivery platform called IBM Consulting Advantage to shorten project timelines.
The structural upgrade spans across multiple core operations including corporate finance, complex pharmaceutical manufacturing, international supply chains, and human resource management departments.
The newly unified digital platform is designed to increase corporate agility, improve data transparency, and strengthen strict regulatory compliance for global drug distribution.
The enterprise systems upgrade will support a long-term growth plan across the manufacturer’s vast footprints throughout the Middle East, Africa, and international markets.
The commercial drug producer operates ten accredited factories inside the United Arab Emirates, anchoring a complex regional supply network that serves over forty nations worldwide.
The technology overhaul updates a diverse medicine portfolio containing more than 300 products addressing critical therapeutic fields such as diabetes, respiratory illnesses, and anti-infectives.
ZOOM OUT - SAP S/4HANA is an enterprise suite built on an in-memory database that eliminates data redundancies to process complex information instantly. By stripping away legacy data silos, the platform creates an open architecture where artificial intelligence, automated robotics, and real-time predictive analytics are directly embedded into daily workflows. Rather than simply recording transactions, the architecture allows organisations to simulate business decisions instantly, automatically spot patterns, and systematically eliminate manual tasks.
[Written and edited with the assistance of AI]
Source: IBM / SAP